(2E)-3-(1,3,5-trimethyl-1H-pyrazol-4-yl)acryloyl chloride
|
- $315 - $924
- Product name: (2E)-3-(1,3,5-trimethyl-1H-pyrazol-4-yl)acryloyl chloride
- CAS: 1173394-98-3
- MF: C9H11ClN2O
- MW: 198.65
- EINECS:
- MDL Number:MFCD12028138
- Synonyms:2-propenoyl chloride, 3-(1,3,5-trimethyl-1H-pyrazol-4-yl)-;(2E)-3-(1,3,5-trimethyl-1H-pyrazol-4-yl)acryloyl chloride;2-propenoyl chloride, 3-(1,3,5-trimethyl-1H-pyrazol-4-yl)-, (2E)-;3-(1,3,5-Trimethyl-1H-pyrazol-4-yl)-2-propenoyl chloride
3 prices
Selected condition：
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Matrix Scientific
Package
- 500mg
- ManufacturerAK Scientific
- Product number9933AC
- Product description(2E)-3-(1,3,5-Trimethyl-1H-pyrazol-4-yl)-acryloylchloride
- Packaging500mg
- Price$475
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0080641
- Product description(2E)-3-(1,3,5-TRIMETHYL-1H-PYRAZOL-4-YL)ACRYLOYL CHLORIDE 95.00%
- Packaging500MG
- Price$924
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number040223
- Product description(2E)-3-(1,3,5-Trimethyl-1H-pyrazol-4-yl)-acryloyl chloride
- Packaging500mg
- Price$315
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 9933AC | (2E)-3-(1,3,5-Trimethyl-1H-pyrazol-4-yl)-acryloylchloride | 500mg | $475 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | CHM0080641 | (2E)-3-(1,3,5-TRIMETHYL-1H-PYRAZOL-4-YL)ACRYLOYL CHLORIDE 95.00% | 500MG | $924 | 2021-12-16 | Buy |
| Matrix Scientific | 040223 | (2E)-3-(1,3,5-Trimethyl-1H-pyrazol-4-yl)-acryloyl chloride | 500mg | $315 | 2021-12-16 | Buy |
Properties
Boiling point :302.0±37.0 °C(Predicted)
Density :1.17±0.1 g/cm3(Predicted)
pka :2.07±0.10(Predicted)
Density :1.17±0.1 g/cm3(Predicted)
pka :2.07±0.10(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|